2564 resected periampullary adenocarcinomas at a single institution: Trends over three decades

HPB

Volumn 16, Issue 1, 2014, Pages 83-90

  He, Jin ^a   Ahuja, Nita ^a   Makary, Martin A ^a   Cameron, John L ^a   Eckhauser, Frederic E ^a   Choti, Michael A ^a   Hruban, Ralph H ^a   Pawlik, Timothy M ^a   Wolfgang, Christopher L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BILE DUCT CANCER; CANCER INCIDENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; DUODENUM CARCINOMA; FEMALE; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALE; PANCREAS; PANCREAS CARCINOMA; PANCREATICODUODENECTOMY; PERIAMPULLARY ADENOCARCINOMA; SURVIVAL RATE; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BALTIMORE; BILE DUCT NEOPLASMS; DUODENAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84890546918     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12078     Document Type: Article

References (35)

1. Sarmiento JM, Nagomey DM, Sarr MG, Farnell MB,. (2001) Periampullary cancers: are there differences? Surg Clin North Am 81: 543-555. (Pubitemid 32612115)
2. Poultsides GA, Huang LC, Cameron JL, Tuli R, Lan L, Hruban RH, et al. (2012) Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment. Ann Surg Oncol 19: 1928-1935.
3. Jemal A, Siegel R, Xu J, Ward E,. (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
4. Khan SA, Toledano MB, Taylor-Robinson SD,. (2008) Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB 10: 77-82. (Pubitemid 351934989)
5. Riall TS, Cameron JL, Lillemoe KD, Winter JM, Campbell KA, Hruban RH, et al. (2006) Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Surgery 140: 764-772. (Pubitemid 44648193)
6. Khan SA, Davidson BR, Goldin RD, Heaton N, Karani J, Pereira SP, et al. (2012) Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut 61: 1657-1669.
7. Sarela AI, Brennan MF, Karpeh MS, Klimstra D, Conlon KC,. (2004) Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer. Ann Surg Oncol 11: 380-386. (Pubitemid 40486747)
8. Howe JR, Klimstra DS, Moccia RD, Conlon KC, Brennan MF,. (1998) Factors predictive of survival in ampullary carcinoma. Ann Surg 228: 87-94. (Pubitemid 30190320)
9. Fong Y, Blumgart LH, Lin E, Fortner JG, Brennan MF,. (1996) Outcome of treatment for distal bile duct cancer. Br J Surg 83: 1712-1715. (Pubitemid 26421867)
10. Cameron JL,. (2005) Pancreaticoduodenectomy is curative in the majority of patients with node-negative ampullary cancer. Arch Surg 140: 708. (Pubitemid 41124011)
11. Cameron JL, Riall TS, Coleman J, Belcher KA,. (2006) One thousand consecutive pancreaticoduodenectomies. Ann Surg 244: 10-15. (Pubitemid 44297442)
12. Falconi M, Crippa S, Dominguez I, Barugola G, Capelli P, Marcucci S, et al. (2008) Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma. Ann Surg Oncol 15: 3178-3186.
13. Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, et al. (2006) 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10: 1199-1210; discussion 1210-1211.
14. Glazer ES, Liu P, Abdalla EK, Vauthey JN, Curley SA,. (2012) Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins. J Gastrointest Surg 16: 1666-1671.
15. Winter JM, Cameron JL, Lillemoe KD, Campbell KA, Chang D, Riall TS, et al. (2006) Periampullary and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosis. Ann Surg 243: 673-680; discussion 680-683. (Pubitemid 44305587)
16. Neoptolemos JP, Moore MJ, Cox TF, Valle JW, Palmer DH, McDonald AC, et al. (2012) Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs. observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA 308: 147-156.
17. Morak MJ, van der Gaast A, Incrocci L, van, Dekken H, Hermans JJ, Jeekel J, et al. (2008) Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial. Ann Surg 248: 1031-1041.
18. Smeenk HG, van Eijck CH, Hop WC, Erdmann J, Tran KC, Debois M, et al. (2007) Longterm survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: longterm results of EORTC trial 40891. Ann Surg 246: 734-740. (Pubitemid 350035648)
19. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138: 8-13. (Pubitemid 40933766)
20. Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR, et al. (2007) Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 142: 761-768. (Pubitemid 350018837)
21. Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Lillemoe KD, Pitt HA,. (1998) Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg 227: 821-831. (Pubitemid 29119529)
22. Nugent FW, Stuart K,. (2010) Adjuvant and neoadjuvant therapy in curable pancreatic cancer. Surg Clin North Am 90: 323-339.
23. Jarufe NP, Coldham C, Mayer AD, Mirza DF, Buckels JA, Bramhall SR,. (2004) Favourable prognostic factors in a large UK experience of adenocarcinoma of the head of the pancreas and periampullary region. Dig Surg 21: 202-209. (Pubitemid 39070131)
24. Hatzaras I, George N, Muscarella P, Melvin WS, Ellison EC, Bloomston M,. (2010) Predictors of survival in periampullary cancers following pancreaticoduodenectomy. Ann Surg Oncol 17: 991-997.
25. Ehehalt F, Rummele P, Kersting S, Lang-Schwarz C, Ruckert F, Hartmann A, et al. (2011) Hepatocyte nuclear factor (HNF) 4alpha expression distinguishes ampullary cancer subtypes and prognosis after resection. Ann Surg 254: 302-310.
26. Embuscado EE, Laheru D, Ricci F, Yun KJ, de, Boom Witzel S, Seigel A, et al. (2005) Immortalizing the complexity of cancer metastasis: genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy. Cancer Biol Ther 4: 548-554. (Pubitemid 41351229)
27. Haeno H, Gonen M, Davis MB, Herman JM, Iacobuzio-Donahue CA, Michor F,. (2012) Computational modelling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell 148: 362-375.
28. Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, et al. (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467: 1114-1117.
29. Yoshimura K, Meckel KF, Laird LS, Chia CY, Park JJ, Olino KL, et al. (2009) Integrin alpha2 mediates selective metastasis to the liver. Cancer Res 69: 7320-7328.
30. Perrone G, Santini D, Zagami M, Vincenzi B, Verzi A, Morini S, et al. (2006) COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters. Virchows Arch 449: 334-340. (Pubitemid 44367975)
31. Ruemmele P, Dietmaier W, Terracciano L, Tornillo L, Bataille F, Kaiser A, et al. (2009) Histopathologic features and microsatellite instability of cancers of the papilla of Vater and their precursor lesions. Am J Surg Pathol 33: 691-704.
32. Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O, et al. (2008) Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma. BMC Cancer 8: 170.
33. Fischer HP, Zhou H,. (2004) Pathogenesis of carcinoma of the papilla of Vater. J Hepatobiliary Pancreat Surg 11: 301-309. (Pubitemid 39485631)
34. Hurtuk MG, Hughes C, Shoup M, Aranha GV,. (2009) Does lymph node ratio impact survival in resected periampullary malignancies? Am J Surg 197: 348-352.
35. van Roest MH, Gouw AS, Peeters PM, Porte RJ, Slooff MJ, Fidler V, et al. (2008) Results of pancreaticoduodenectomy in patients with periampullary adenocarcinoma: perineural growth more important prognostic factor than tumour localization. Ann Surg 248: 97-103.